Le Lézard
Classified in: Health
Subject: SVY

$4.8 Bn Urinary Incontinence Devices Market - Global Outlook to 2026


DUBLIN, July 15, 2019 /PRNewswire/ -- The "Urinary Incontinence Devices - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Global Urinary Incontinence Devices market accounted for $1,634.23 Million in 2017 and is expected to reach $4,804.40 Million by 2026 growing at a CAGR of 12.7% from 2017 to 2026.

Some of the factors such as increasing demand for minimally invasive or non-surgical products, rising incidence of Parkinson's disease and development of innovative urinary incontinence devices are driving market growth. Moreover, growth of healthcare expenditure in developing economies will provide ample opportunities for market growth. However, factors such as less awareness of novel developments and post-operative problems related with the devices hampers the market growth.

Urinary incontinence is uncontrolled leakage of urine due to loss of bladder control. Many people across the world are affected by urinary incontinence and women are more affected than men. Factors such as Pelvic surgery, pregnancy, urethral sphincters, menopause, and childbirth, and post radical prostatectomy surgery leads to the development of urinary incontinence. Urinary incontinence is highly under-reported primarily due to embarrassment to speak about it. It is over and over again a result of an underlying medical condition but is under-reported to medical practitioners.

By Product, the Electrical Stimulation Device segment registered significant share during the forecast period. The Electrical Stimulation Device is used to treat urinary incontinence by sending a mild electric current to nerves in the lower back or the pelvic muscles that are involved in urination. By geography, North America dominated the largest market share due to favourable medical compensation policies, well-established health care facilities and early adoption of technically superior products for the management of urinary incontinence.

What the report offers:

Key Topics Covered:

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.5 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Urinary Incontinence Devices Market, By Product
5.1 Introduction
5.2 Vaginal Slings
5.2.1 Advanced Vaginal Slings
5.2.2 Conventional Vaginal Slings
5.3 Urinary Catheters
5.3.1 Foley Catheters
5.3.2 Other Urinary Catheters
5.4 Electrical Stimulation Devices
5.4.1 Non-Implantable
5.4.2 Implantable
5.5 Urethral Slings
5.5.1 Male Slings
5.5.2 Female Slings
5.6 Neuromodulation Devices
5.7 Artificial Urinary Sphincters
5.8 Other Products

6 Global Urinary Incontinence Devices Market, By Category
6.1 Introduction
6.2 External Urinary Incontinence Devices
6.3 Internal Urinary Incontinence Devices

7 Global Urinary Incontinence Devices Market, By Incontinence Type
7.1 Introduction
7.2 Urge Urinary Incontinence
7.3 Functional Urinary Incontinence
7.4 Stress Urinary Incontinence
7.5 Overflow Urinary Incontinence

8 Global Urinary Incontinence Devices Market, By End User
8.1 Introduction
8.2 Clinics
8.3 Hospitals
8.4 Ambulatory Surgery Centers
8.5 Home Use
8.6 Other End Users

9 Global Urinary Incontinence Devices Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Cogentix Medical Inc.
11.2 Cook Medical
11.3 ProSurg Inc.
11.4 Coloplast A/S
11.5 Boston Scientific Corporation
11.6 Promedon Group
11.7 ZSI Surgical Implants S.R.L.
11.8 Caldera Medical
11.9 A.M.I. GmbH
11.10 C.R. Bard Inc.
11.11 Medtronic plc
11.12 Atlantic Therapeutics Group Ltd
11.13 Teleflex Incorporated
11.14 B. Braun Melsungen AG
11.15 Incontrol Medical LLC

For more information about this report visit https://www.researchandmarkets.com/r/md92tf

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



SOURCE Research and Markets


These press releases may also interest you

at 11:02
The American College of Clinical Pharmacology® (ACCP) is pleased to announce its 2024 ACCP Annual Meeting (#2024ACCP) will be held September 8 ? 10, 2024. We encourage you to join us for this transformative educational and scientific event! ACCP...

at 11:01
Somavedic, a trailblazer in sleep and digital pollution-neutralizing frequency therapy technology, in collaboration with researchers from the Eye Clinic of Jan Evangelista Purkyn? University and Masaryk Hospital in Ústí nad Labem in the Czech...

at 11:00
The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER) studies, research to strengthen...

at 11:00
Health Canada is advising that the following product(s) may pose serious health risks. For more information, including product photos and what you should do, visit these online safety alerts: ?  Unauthorized sexual enhancement products Health Canada...

at 11:00
Every treatment prescribed by a doctor today was once a part of research in a clinical trial. Clinical research is thriving at Thompson Cancer Survival Center....

at 10:59
According to the second annual Workplace Violence Prevention Training Annual Report for health care ? which provides insight into the state of workplace violence prevention training in health care ? the majority of health care professionals surveyed...



News published on and distributed by: